Published in Cell on November 11, 2011
What we talk about when we talk about fat. Cell (2014) 4.12
Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nat Med (2015) 2.23
A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med (2014) 1.83
Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis. EMBO J (2012) 1.80
Thyroid hormone regulation of metabolism. Physiol Rev (2014) 1.70
Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov (2013) 1.66
Genome-wide map of nuclear protein degradation shows NCoR1 turnover as a key to mitochondrial gene regulation. Cell (2013) 1.55
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab (2014) 1.53
Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell (2014) 1.53
NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. Cell (2013) 1.22
Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes (2012) 1.22
Inflammation, obesity, and thrombosis. Blood (2013) 1.21
Emerging roles of the corepressors NCoR1 and SMRT in homeostasis. Genes Dev (2013) 1.18
A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods. Mol Endocrinol (2012) 1.13
The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature (2015) 1.11
Amorfrutins are potent antidiabetic dietary natural products. Proc Natl Acad Sci U S A (2012) 1.09
S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis. J Clin Invest (2015) 1.06
Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. J Clin Invest (2013) 1.04
The corepressor NCoR1 antagonizes PGC-1α and estrogen-related receptor α in the regulation of skeletal muscle function and oxidative metabolism. Mol Cell Biol (2012) 1.02
Insulin signalling mechanisms for triacylglycerol storage. Diabetologia (2013) 1.00
Metabolic reprogramming by class I and II histone deacetylases. Trends Endocrinol Metab (2012) 0.98
The in vivo role of nuclear receptor corepressors in thyroid hormone action. Biochim Biophys Acta (2012) 0.98
G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice. J Clin Invest (2012) 0.97
The PPARα-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway. Cell Metab (2014) 0.95
PPARs and ERRs: molecular mediators of mitochondrial metabolism. Curr Opin Cell Biol (2014) 0.94
Transcriptional coregulators: fine-tuning metabolism. Cell Metab (2014) 0.93
Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Mol Metab (2015) 0.92
Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ. Biochim Biophys Acta (2012) 0.91
SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation. J Clin Invest (2012) 0.91
Improving insulin sensitivity with HDAC inhibitor. Diabetes (2013) 0.90
Coordinated Regulation of PPARγ Expression and Activity through Control of Chromatin Structure in Adipogenesis and Obesity. PPAR Res (2012) 0.89
Adipose tissue signaling by nuclear receptors in metabolic complications of obesity. Adipocyte (2012) 0.88
Revisiting PPARγ as a target for the treatment of metabolic disorders. BMB Rep (2014) 0.85
Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance. Am J Physiol Endocrinol Metab (2014) 0.85
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med (2014) 0.84
Exploring the emerging complexity in transcriptional regulation of energy homeostasis. Nat Rev Genet (2015) 0.83
ARTD1-induced poly-ADP-ribose formation enhances PPARγ ligand binding and co-factor exchange. Nucleic Acids Res (2014) 0.82
Nuclear Mechanisms of Insulin Resistance. Trends Cell Biol (2016) 0.81
Cdk5 controls IL-2 gene expression via repression of the mSin3a-HDAC complex. Cell Cycle (2015) 0.81
Brown fat determination and development from muscle precursor cells by novel action of bone morphogenetic protein 6. PLoS One (2014) 0.81
Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming. Genes Dev (2014) 0.81
P65 inactivation in adipocytes and macrophages attenuates adipose inflammatory response in lean but not in obese mice. Am J Physiol Endocrinol Metab (2015) 0.81
Transcriptional Regulation by Nuclear Corepressors and PGC-1α: Implications for Mitochondrial Quality Control and Insulin Sensitivity. PPAR Res (2012) 0.80
p75 Neurotrophin Receptor Regulates Energy Balance in Obesity. Cell Rep (2015) 0.80
Alteration of NCoR corepressor splicing in mice causes increased body weight and hepatosteatosis without glucose intolerance. Mol Cell Biol (2014) 0.79
Obesity and cancer, a case for insulin signaling. Cell Death Dis (2015) 0.79
Low birth weight male guinea pig offspring display increased visceral adiposity in early adulthood. PLoS One (2014) 0.79
NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. Mol Cell Biol (2014) 0.78
Programmed regulation of rat offspring adipogenic transcription factor (PPARγ) by maternal nutrition. J Dev Orig Health Dis (2015) 0.78
Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling. Mol Cell Endocrinol (2015) 0.78
Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway. J Clin Invest (2014) 0.78
The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2. J Biol Chem (2014) 0.78
Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovaries. J Steroid Biochem Mol Biol (2016) 0.77
Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity. Nucleic Acids Res (2015) 0.77
CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes. Cell Death Dis (2014) 0.77
Derepressing nuclear receptors for metabolic adaptation. Cell (2011) 0.77
Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications. Yonsei Med J (2013) 0.77
Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes. Mol Endocrinol (2015) 0.77
Couple dynamics: PPARγ and its ligand partners. Structure (2012) 0.77
Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect. PLoS One (2015) 0.76
α/β-hydrolase domain containing protein 15 (ABHD15)--an adipogenic protein protecting from apoptosis. PLoS One (2013) 0.76
Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A (2017) 0.76
Transcriptional repression of mitochondrial function in aging: a novel role for the silencing mediator of retinoid and thyroid hormone receptors co-repressor. Antioxid Redox Signal (2012) 0.75
FAK signalling controls insulin sensitivity through regulation of adipocyte survival. Nat Commun (2017) 0.75
Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes. Mol Cell Endocrinol (2015) 0.75
Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function. Curr Genomics (2014) 0.75
LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties. J Biol Chem (2014) 0.75
The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice. EMBO Rep (2017) 0.75
FADD is a key regulator of lipid metabolism. EMBO Mol Med (2016) 0.75
Ubiquitin specific protease 19 involved in transcriptional repression of retinoic acid receptor by stabilizing CORO2A. Oncotarget (2016) 0.75
The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells. J Cell Physiol (2016) 0.75
The Synergistic Enhancement of Cloning Efficiency in Individualized Human Pluripotent Stem Cells by Peroxisome Proliferative-activated Receptor-γ (PPARγ) Activation and Rho-associated Kinase (ROCK) Inhibition. J Biol Chem (2015) 0.75
Naturally improving insulin resistance with amorfrutins. Proc Natl Acad Sci U S A (2012) 0.75
Effects of low-fat diet and aging on metabolic profiles of Creb3l4 knockout mice. Nutr Diabetes (2015) 0.75
Epigenomic and transcriptional control of insulin resistance. J Intern Med (2016) 0.75
Allele compensation in tip60+/- mice rescues white adipose tissue function in vivo. PLoS One (2014) 0.75
CD301b(+) Mononuclear Phagocytes Maintain Positive Energy Balance through Secretion of Resistin-like Molecule Alpha. Immunity (2016) 0.75
Bisphenol A and Bisphenol S Induce Distinct Transcriptional Profiles in Differentiating Human Primary Preadipocytes. PLoS One (2016) 0.75
Adipose tissue NAD(+)-homeostasis, sirtuins and poly(ADP-ribose) polymerases - important players in mitochondrial metabolism and metabolic health. Redox Biol (2017) 0.75
Autocrine effect of vascular endothelial growth factor-A is essential for mitochondrial function in brown adipocytes. Metabolism (2015) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (1995) 11.53
A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (1995) 11.18
Obesity and insulin resistance. J Clin Invest (2000) 10.47
Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem (2008) 9.56
Adipocytes as regulators of energy balance and glucose homeostasis. Nature (2006) 9.52
Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci (1959) 8.62
Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 8.30
PPARs and the complex journey to obesity. Nat Med (2004) 7.44
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A (2003) 6.82
A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem (2007) 6.58
The many faces of PPARgamma. Cell (2005) 6.24
Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol (2008) 5.61
The role of exercise and PGC1alpha in inflammation and chronic disease. Nature (2008) 5.31
A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science (2008) 5.28
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01
Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest (2007) 4.86
Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev (2007) 4.23
Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell (2000) 3.47
Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes (1996) 3.21
Nuclear receptors and the control of metabolism. Annu Rev Physiol (2002) 3.00
Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A (2004) 2.46
Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol (2007) 2.40
PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc Natl Acad Sci U S A (2009) 2.38
Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab (2002) 2.33
Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab (2008) 2.28
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav (2007) 2.23
The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am (2008) 2.20
Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J Biol Chem (2010) 2.14
The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem (2005) 1.99
The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep (2010) 1.98
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci (2004) 1.97
Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol (1999) 1.85
Adipocyte CREB promotes insulin resistance in obesity. Cell Metab (2009) 1.72
Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc Natl Acad Sci U S A (2010) 1.60
Expanding functional diversity of the coactivators. Trends Biochem Sci (2005) 1.57
Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes (2007) 1.32
Inducible nitric oxide synthase deficiency in myeloid cells does not prevent diet-induced insulin resistance. Mol Endocrinol (2010) 1.02
Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants. Diabetes Metab Res Rev (2010) 0.85
Viral mechanisms involved in the transcriptional CBP/p300 regulation of inflammatory and immune responses. Crit Rev Immunol (2009) 0.80
Dynamic control of nuclear receptor transcription. Sci STKE (2004) 0.79
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet (2007) 19.18
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature (2004) 12.36
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature (2007) 10.21
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Inflammation in prostate carcinogenesis. Nat Rev Cancer (2007) 9.08
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell (2010) 8.69
Collection, mapping, and annotation of over 28,000 cDNA clones from japonica rice. Science (2003) 8.65
TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A (2003) 6.82
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med (2009) 6.61
Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest (2008) 6.60
A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem (2007) 6.58
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet (2002) 6.02
The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 5.63
Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med (2012) 5.49
Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab (2008) 5.44
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem (2003) 5.40
JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab (2007) 5.38
Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 5.10
Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest (2007) 4.86
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature (2005) 4.71
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest (2004) 4.65
H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet (2007) 4.62
Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov (2008) 4.43
Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab (2008) 4.36
SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell (2002) 4.31
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst (2007) 4.24
Mitonuclear protein imbalance as a conserved longevity mechanism. Nature (2013) 4.18
Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science (2011) 4.16
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature (2012) 4.15
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A (2003) 4.03
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature (2008) 3.98
Muscle-specific Pparg deletion causes insulin resistance. Nat Med (2003) 3.93
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet (2010) 3.83
A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol (2002) 3.59
Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A (2001) 3.58
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology (2010) 3.52
The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell (2013) 3.50
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48
Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab (2010) 3.46
Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A (2010) 3.41
Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem (2003) 3.41
Inflammation and insulin resistance. FEBS Lett (2007) 3.34
PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A (2006) 3.29
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev (2009) 3.23
Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab (2006) 3.22
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med (2012) 3.21
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab (2012) 3.18
Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice. Nat Med (2013) 3.15
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes (2002) 3.15
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14
Inflamed fat: what starts the fire? J Clin Invest (2006) 3.11
Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab (2009) 3.10
Development of a novel mouse glioma model using lentiviral vectors. Nat Med (2009) 3.08
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A (2010) 3.03
Endocrine functions of bile acids. EMBO J (2006) 3.03
Nuclear receptors and the control of metabolism. Annu Rev Physiol (2002) 3.00
Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr (2011) 2.98
Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med (2010) 2.98
Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab (2012) 2.96
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J (2002) 2.82
JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem (2005) 2.76
NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell (2011) 2.75
Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat Med (2011) 2.74
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol (2008) 2.73
E2Fs regulate adipocyte differentiation. Dev Cell (2002) 2.71
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother (2012) 2.65
Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med (2007) 2.64
Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. Eur Urol (2011) 2.62
The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell (2002) 2.61
Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet (2001) 2.61
Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology (2003) 2.59
Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes. Nature (2005) 2.54
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51